Nouf Alhammadi, Mushary Alqahtani, Khaled A. Amer, Abdullah AL Thawwab, Ahmed S. AL Zomia, Hanan Alqahtani, Fares A. Alshahrani, Abdussalam Alqhtani, Dalia A. Al Mubarak, Fahad S. Alahmari, Shahad S. Al-Qahtani, Muhammed A. Alkhairi, Noura S. Alhudaithi & Hind A. Asiri·Journal of Pharmaceutical Research International·2024
Introduction: Behçet's disease (BD) is a chronic, multisystem inflammatory disorder characterized by a diverse array of clinical manifestations, including recurrent oral and genital ulcers, ocular inflammation, skin lesions, and joint problems. Its presentation varies, requiring...
Open access
Research Article10.9734/jpri/2024/v36i117611
Introduction: COVID-19's emergence caused devastating consequences worldwide, with high morbidity and mortality rates. Critically ill patients face challenges like acute respiratory failure requiring intensive measures, including mechanical ventilation. Mortality rates in ARDS ar...
Open access
Research Article10.9734/jpri/2024/v36i87562
Nouf A Alhammadi, Mushary S. Alqahtani, Khaled A. Amer, Abdullah AL Thawwab, Ahmed Saad Al Zomia, Hanan Alqahtani, Fares Ayed Alshahrani, Mohammed Abdullah Alshehri, Nasser Saidan Alaslai, Maram Ali AlShahrani, Raghad Saad Alshahrani, Arwa Ayed Alshahrani, Batool Abdullah Alahmary & Fahad Abdulruhman Alazragi·Journal of Pharmaceutical Research International·2024
Background: Behçet's disease (BD) is a rare, chronic inflammatory disorder that recurs over time, impacting multiple systems, positioning it at the intersection of autoimmune and auto-inflammatory syndromes. BD is a unique clinical entity known for its diverse manifestations with...
Open access
Research Article10.9734/jpri/2024/v36i77548